346
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Nomograms for predicting survival in early-onset esophageal cancer

ORCID Icon, ORCID Icon & ORCID Icon
Pages 437-446 | Received 21 Jun 2020, Accepted 22 Oct 2020, Published online: 15 Nov 2020

References

  • Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013 Feb 2;381(9864):400–412.
  • Then EO, Lopez M, Saleem S, et al. Esophageal cancer: an updated surveillance epidemiology and end results database analysis. World J Oncol. 2020 Apr;11(2):55–64. .
  • Lepage C, Rachet B, Jooste V, et al. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol. 2008 Nov;103(11):2694–2699. .
  • Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013 Sep 14;19(34):5598–5606.
  • Islami F, DeSantis CE, Jemal A. Incidence trends of esophageal and gastric cancer subtypes by race, ethnicity, and age in the United States, 1997-2014. Clin Gastroenterol Hepatol. 2019 Feb;17(3):429–439.
  • Sawas T, Manrique GC, Iyer PG, et al. Young adults with esophageal adenocarcinoma present with more advanced stage tumors and have shorter survival times. Clin Gastroenterol Hepatol. 2019 Aug;17(9):1756–1762.
  • Wang B, Gu W, Wan F, et al. Prognosis of the 8th TNM staging system for penile cancer and refinement of prognostication by incorporating high risk human papillomavirus status. J Urol. 2020 Mar;203(3):562–569. .
  • Jain N, Mostoufi-Moab S, Hawkes C, et al. Extrathyroidal extension is an important predictor of regional lymph node metastasis in pediatric differentiated thyroid cancer. Thyroid. 2020;30(7):1037–1043. .
  • Park SY, Cho YY, Kim HI, et al. Clinical validation of the prognostic stage groups of the eighth-edition TNM staging for medullary thyroid carcinoma. J Clin Endocrinol Metab. 2018 Dec 1;103(12):4609–4616.
  • Yu Z, Yang J, Gao L, et al. A competing risk analysis study of prognosis in patients with esophageal carcinoma 2006-2015 using data from the Surveillance, Epidemiology, and End Results (SEER) database. Med Sci Monit. 2020 Jan 22;26:e918686. .
  • Zhu C, You Y, Liu S, et al. A nomogram to predict distant metastasis for patients with esophageal cancer. Oncol Res Treat. 2020;43(1–2):2–9. .
  • van Nistelrooij AM, van Steenbergen LN, Spaander MC, et al. Treatment and outcome of young patients with esophageal cancer in the Netherlands. J Surg Oncol. 2014 May;109(6):561–566. .
  • Zeng Y, Ruan W, Liu J, et al. Esophageal cancer in patients under 50: a SEER analysis. J Thorac Dis. 2018 May;10(5):2542–2550. .
  • Di Corpo M, Schlottmann F, Strassle PD, et al. Treatment modalities for esophageal adenocarcinoma in the United States: trends and survival outcomes. J Laparoendosc Adv Surg Tech A. 2019 Aug;29(8):989–994. .
  • White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011 Feb 20;30(4):377–399.
  • Deng J, Chu X, Ren Z, et al. Relationship between T stage and survival in distantly metastatic esophageal cancer: A STROBE-compliant study. Medicine (Baltimore). 2020 May;99(19):e20064. .
  • Shi M, Zhou B, Yang SP. Nomograms for predicting overall survival and cancer-specific survival in young patients with pancreatic cancer in the US based on the SEER database. PeerJ. 2020;8:e8958.
  • Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006 Nov-Dec;26(6):565–574.
  • Shaheen NJ, Falk GW, Iyer PG, et al. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016 Jan;111(1):30–50. quiz 51.
  • Wu XX, Chen RP, Chen RC, et al. Nomogram predicting cancer-specific mortality in patients with esophageal adenocarcinoma: a competing risk analysis. J Thorac Dis. 2019 Jul;11(7):2990–3003. .
  • Birkmeyer NJ, Gu N, Baser O, et al. Socioeconomic status and surgical mortality in the elderly. Med Care. 2008 Sep;46(9):893–899. .
  • Tramontano AC, Nipp R, Mercaldo ND, et al. Survival disparities by race and ethnicity in early esophageal cancer. Dig Dis Sci. 2018 Nov;63(11):2880–2888. .
  • Revels SL, Morris AM, Reddy RM, et al. Racial disparities in esophageal cancer outcomes. Ann Surg Oncol. 2013 Apr;20(4):1136–1141. .
  • Kauppila JH, Wahlin K, Lagergren P, et al. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma. Int J Cancer. 2019 Mar 15;144(6):1284–1291.
  • Qiu MJ, Yang SL, Wang MM, et al. Prognostic evaluation of esophageal cancer patients with stages I-III. Aging (Albany NY). 2020 Jul 23;12(14):14736–14753.
  • Xie SH, Lagergren J. The male predominance in esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2016 Mar;14(3):338–47 e1.
  • Petrick JL, Falk RT, Hyland PL, et al. Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR study. PLoS One. 2018;13(1):e0190325. .
  • Xie SH, Ness-Jensen E, Rabbani S, et al. Circulating sex hormone levels and risk of esophageal adenocarcinoma in a prospective study in men. Am J Gastroenterol. 2020 Feb;115(2):216–223. .
  • Zhang QW, Lin XL, Zhang CH, et al. The influence of marital status on the survival of patients with esophageal cancer: a population-based, propensity-matched study. Oncotarget. 2017 Sep 22;8(37):62261–62273.
  • Du L, Kim JJ, Chen B, et al. Marital status is associated with superior survival in patients with esophageal cancer: a surveillance, epidemiology, and end results study. Oncotarget. 2017 Nov 10;8(56):95965–95972.
  • Aizer AA, Chen MH, McCarthy EP, et al. Marital status and survival in patients with cancer. J Clin Oncol. 2013 Nov 1;31(31):3869–3876. .
  • Jung HK, Tae CH, Lee HA, et al. Treatment pattern and overall survival in esophageal cancer during a 13-year period: a nationwide cohort study of 6,354 Korean patients. PLoS One. 2020;15(4):e0231456.
  • Chadwick G, Riley S, Hardwick RH, et al. Population-based cohort study of the management and survival of patients with early-stage oesophageal adenocarcinoma in England. Br J Surg. 2016 Apr;103(5):544–552. .
  • van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012 May 31;366(22):2074–2084.
  • Oppedijk V, van der Gaast A, van Lanschot JJ, et al. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. J Clin Oncol. 2014 Feb 10;32(5):385–391.
  • Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999 May 5;281(17):1623–1627.
  • Du F, Sun Z, Jia J, et al. Development and validation of an individualized nomogram for predicting survival in patients with esophageal carcinoma after resection. J Cancer. 2020;11(14):4023–4029. .
  • Domper Arnal MJ, Ferrandez Arenas A, Lanas Arbeloa A. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015 Jul 14;21(26):7933–7943.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.